42 Results

People

  1. Motzer
    Motzer
  2. Saltz
    Saltz
  3. Abou-Alfa
    Abou-Alfa
  4. Dickler
    Dickler
  5. Feldman
    Feldman
  6. Gil-Bazo
    Gil-Bazo
  7. Kotecha
    Kotecha
  8. Patil
    Patil
  9. Reidy
    Reidy
  10. Voss
    Voss

Groups

  1. Department of Medicine (26)
  2. Solid Tumor Oncology Division (24)
  3. Genitourinary Oncology Service (9)
  4. Gastrointestinal Oncology Service (7)
  5. GSK Faculty (6)
  6. Radiology, Department of (6)
  7. Body Imaging Service (5)
  8. Breast Medicine Service (4)
  9. Epidemiology and Biostatistics (4)
  10. Hematologic Malignancies, Division of (4)
  1. "vegf"
Formats
  1. Journal Article (38)
  2. Book Section (2)
  3. Conference Paper (1)
  4. Meeting Abstract (1)
Groups
  1. Department of Medicine (26)
  2. Solid Tumor Oncology Division (24)
  3. Genitourinary Oncology Service (9)
  4. Gastrointestinal Oncology Service (7)
  5. GSK Faculty (6)
  6. Radiology, Department of (6)

More Groups

People
  1. Robert Motzer (8)
  2. Leonard Saltz (4)
  3. Chung-Han Lee (2)
  4. Darren Feldman (2)
  5. Diane Reidy (2)
  6. Ghassan Abou-Alfa (2)

More People

Years
  1. 2025 (1)
  2. 2023 (1)
  3. 2021 (4)
  4. 2020 (1)
  5. 2019 (1)
  6. 2018 (2)

More Years

Publications
  1. Clinical Genitourinary Cancer (3)
  2. Breast Cancer Research and Treatment (2)
  3. Advanced Materials (1)
  4. Angiogenesis (1)
  5. Annual Northeast Biomedical Engineering Conference. Proceedings (1)
  6. BJU International (1)

More Publications

Publishers
  1. Elsevier Inc. (9)
  2. Springer (8)
  3. American Association for Cancer Research (2)
  4. Informa Healthcare (2)
  5. Lippincott Williams & Wilkins (2)
  6. Nature Publishing Group (2)

More Publishers

Results (42)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Optimizing postneoadjuvant treatment of residual breast cancer with adjuvant bevacizumab alone, with metronomic or standard-dose chemotherapy: A combined analysis of DFCI 05-055 and DFCI 09-134/TBCRC 012/ABCDE clinical trials
    Journal Article

    Trapani, D.; Jin, Q.; Miller, K. D.; Rugo, H. S.; Reeder-Hayes, K. E.; Traina, T.; Abdou, Y.; Falkson, C.; Abramson, V.; Ligibel, J.; more...
    Clinical Breast Cancer (2025)

    Fulltext@MSK | Save
  • Short report of a phase ii trial of nintedanib in recurrent malignant pleural mesothelioma (MPM)
    Journal Article

    Wozniak, A. J.; Schneider, B.; Kalemkerian, G. P.; Daly, B.; Chen, W.; Ventimiglia, J.; Nagasaka, M.; Zauderer, M. G.
    Clinical Lung Cancer (2023)

    Fulltext@MSK | Save
  • Bevacizumab in advanced endometrial cancer
    Journal Article

    Rubinstein, M. M.; Dickinson, S.; Narayan, P.; Zhou, Q.; Iasonos, A.; Ma, W.; Lakhman, Y.; Makker, V.
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save
  • Phase 1b study of galunisertib and ramucirumab in patients with advanced hepatocellular carcinoma
    Journal Article

    Harding, J. J.; Do, R. K.; Yaqubie, A.; Cleverly, A.; Zhao, Y.; Gueorguieva, I.; Lahn, M.; Benhadji, K. A.; Kelley, R. K.; Abou-Alfa, G. K.
    Cancer Medicine (2021)

    Fulltext@MSK | Save
  • Bispecific T-cell engaging antibodies against MUC16 demonstrate efficacy against ovarian cancer in monotherapy and in combination with PD-1 and VEGF inhibition
    Journal Article

    Yeku, O. O.; Rao, T. D.; Laster, I.; Kononenko, A.; Purdon, T. J.; Wang, P.; Cui, Z.; Liu, H.; Brentjens, R. J.; Spriggs, D.
    Frontiers in Immunology (2021)

    Fulltext@MSK | Save
  • Regression of intracranial meningiomas following treatment with cabozantinib
    Journal Article

    Kotecha, R.; Tonse, R.; Appel, H.; Odia, Y.; Kotecha, R. R.; Rabinowits, G.; Mehta, M. P.
    Current Oncology (2021)

    Fulltext@MSK | Save
  • Systemic therapy for advanced clear cell renal cell carcinoma after discontinuation of immune-oncology and VEGF targeted therapy combinations
    Journal Article

    Ged, Y.; Gupta, R.; Duzgol, C.; Knezevic, A.; Shapnik, N.; Kotecha, R.; Voss, M. H.; Feldman, D. R.; Akin, O.; Patil, S.; more...
    BMC Urology (2020)

    Fulltext@MSK | Save
  • COMPARZ post hoc analysis: Characterizing pazopanib responders with advanced renal cell carcinoma
    Journal Article

    Sternberg, C. N.; Motzer, R. J.; Hutson, T. E.; Choueiri, T. K.; Kollmannsberger, C.; Bjarnason, G. A.; Paul, Nathan; Porta, C.; Grünwald, V.; Dezzani, L.; more...
    Clinical Genitourinary Cancer (2019)

    Fulltext@MSK | Save
  • Construction of a novel bispecific antibody to enhance antitumor activity against lung cancer
    Journal Article

    Yin, W.; Zhu, J.; Gonzalez-Rivas, D.; Okumura, M.; Rocco, G.; Pass, H.; Jiang, G.; Yang, Y.
    Advanced Materials (2018)

    Fulltext@MSK | Save
  • Histopathologic characteristics of background parenchymal enhancement (BPE) on breast MRI
    Journal Article

    Sung, J. S.; Corben, A. D.; Brooks, J. D.; Edelweiss, M.; Keating, D. M.; Lin, C.; Morris, E. A.; Patel, P.; Robson, M.; Woods, M.; more...
    Breast Cancer Research and Treatment (2018)

    Fulltext@MSK | Save